1-108816177-T-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_152763.5(AKNAD1):c.2505A>C(p.Lys835Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000954 in 1,604,424 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152763.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKNAD1 | NM_152763.5 | c.2505A>C | p.Lys835Asn | missense_variant | Exon 16 of 16 | ENST00000370001.8 | NP_689976.2 | |
AKNAD1 | NR_049760.2 | n.2635A>C | non_coding_transcript_exon_variant | Exon 14 of 14 | ||||
LOC105378891 | XR_007066280.1 | n.53+2535T>G | intron_variant | Intron 1 of 2 | ||||
LOC105378891 | XR_947687.3 | n.53+2535T>G | intron_variant | Intron 1 of 4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000411 AC: 10AN: 243512 AF XY: 0.0000304 show subpopulations
GnomAD4 exome AF: 0.000103 AC: 149AN: 1452242Hom.: 0 Cov.: 32 AF XY: 0.0000984 AC XY: 71AN XY: 721728 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74358 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2505A>C (p.K835N) alteration is located in exon 16 (coding exon 15) of the AKNAD1 gene. This alteration results from a A to C substitution at nucleotide position 2505, causing the lysine (K) at amino acid position 835 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at